Welcome

About Us

RNA Australia will lead the development of a robust RNA research and development ecosystem in New South Wales. It was established in March 2023 as a joint venture between the NSW Government and five founding university member. 

Key Objectives of RNA Australia:

  • Support the sustainable operations of the RNA Research and Pilot Manufacturing Facility towards achieving the desired commercial RNA R&D, products and services.
  • Develop and support R&D and commercialisation of world-leading relevant technologies and therapeutics.
  • Accelerate RNA R&D into new commercial products, services and expertise including delivery of vaccine.
  • Target RNA therapies in medical applications, agriculture, biosecurity and other relevant sectors.
  • Improve accessibility of advanced RNA technology therapies for humans and animals.
  • Boost a strong network between universities, research organisations, industries, entrepreneurs and investors.
  • Foster essential skills and pathways for innovation, R&D, manufacturing and commercialisation.

Opportunity for:

  • Access to Open-source GMP Facility (from 2025) aimed at scaling and producing RNA therapeutics for Phase 1-3 clinical trials alongside the NSW clinical trial system.
  • Collaboration and partnership with industry and universities including the 14 NSW and ACT universities.
  • Intellectual property development with support from the RNA ecosystem.
  • Investment in RNA developments and other related RNA activities.